Women's Health (168)
New caffeine research published in the British Journal of Pharmacology reveals that caffeine consumption may make it harder for a woman to get pregnant.
New caffeine research reveals that caffeine consumption may make it harder for a woman to get pregnant.
Babies born at very low birth weights struggle in their early years and a new study by University of Wisconsin-Madison researchers suggests that their mothers do, too.
Nearly 50 million people, suffered mental illness in the past year with women and young adults more susceptible, according to a new report on Mental Illness by the Substance Abuse and Mental Health Services Administration.
Pelvic pain and abnormal bleeding aren’t the only signs of gynecologic cancer, which includes cervical cancer, ovarian cancer or uterine cancer (also known as endometrial cancer).
As part of Cervical Health Awareness Month in January, cancer experts at The University of Texas MD Anderson Cancer Center share other gynecologic cancer symptoms that often are overlooked.
HHS Restricts Over-the-counter Plan B Birth Control Access to Girls Younger than 17
Plan B-One Step, the so-called "morning after pill," will not be made available over the counter to girls younger than 17, regardless of a previous Food and Drug Administration (FDA) recommendation, according to a statement by U.S. Department of Health & Human Services (HHS) Secretary Kathleen Sebelius.
ften people think that periodontal disease is a condition associated with old age, but periodontal disease (gum disease) is blind to gender and age. Several studies about periodontal disease is proving that periodontal disease (gum disease) is a threat to all people, regardless of age.
High heels may turn heads, but new research shows the long-term cost of wearing them is even steeper than the sky-high price tag of some coveted brands.
Along with aching feet and a variety of foot deformities, years of high-heel wearing can actually alter the anatomy of the calf muscles and tendons, according to a study by researchers in England, published online July 16 in the Journal of Experimental Biology.
An FDA advisory panel unanimously rejected what some had hoped would become the first drug approved to boost sexual desire in women. The drug flibanserin, dubbed "female Viagra," showed little evidence of working and raised safety concerns according to the FDA advisory panel.
If the FDA follows the recommendation of the advisory panel, it would send drugmakers back to the lab in their quest to come up with a libido enhancing drug for women.
Women who took the birth control pill beginning in the late 1960s lived longer than those never on the pill, according to a new study published in the British Medical Journal, BMJ.